NM_206965.2:c.1409G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_206965.2(FTCD):​c.1409G>A​(p.Arg470Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00114 in 1,586,500 control chromosomes in the GnomAD database, including 14 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R470W) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0013 ( 4 hom., cov: 33)
Exomes 𝑓: 0.0011 ( 10 hom. )

Consequence

FTCD
NM_206965.2 missense

Scores

19

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -1.54

Publications

4 publications found
Variant links:
Genes affected
FTCD (HGNC:3974): (formimidoyltransferase cyclodeaminase) The protein encoded by this gene is a bifunctional enzyme that channels 1-carbon units from formiminoglutamate, a metabolite of the histidine degradation pathway, to the folate pool. Mutations in this gene are associated with glutamate formiminotransferase deficiency. Alternatively spliced transcript variants have been found for this gene.[provided by RefSeq, Dec 2009]
FTCD Gene-Disease associations (from GenCC):
  • formiminoglutamic aciduria
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Orphanet, Laboratory for Molecular Medicine

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0057617426).
BP6
Variant 21-46138542-C-T is Benign according to our data. Variant chr21-46138542-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 340416.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00128 (195/152254) while in subpopulation AMR AF = 0.00118 (18/15308). AF 95% confidence interval is 0.00076. There are 4 homozygotes in GnomAd4. There are 85 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 4 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FTCDNM_206965.2 linkc.1409G>A p.Arg470Gln missense_variant Exon 12 of 14 ENST00000397746.8 NP_996848.1
FTCDNM_001320412.2 linkc.1409G>A p.Arg470Gln missense_variant Exon 12 of 15 NP_001307341.1
FTCDNM_006657.3 linkc.1409G>A p.Arg470Gln missense_variant Exon 12 of 15 NP_006648.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FTCDENST00000397746.8 linkc.1409G>A p.Arg470Gln missense_variant Exon 12 of 14 1 NM_206965.2 ENSP00000380854.3

Frequencies

GnomAD3 genomes
AF:
0.00128
AC:
194
AN:
152136
Hom.:
4
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00118
Gnomad ASJ
AF:
0.0282
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.000828
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000882
Gnomad OTH
AF:
0.00144
GnomAD2 exomes
AF:
0.00212
AC:
424
AN:
199810
AF XY:
0.00217
show subpopulations
Gnomad AFR exome
AF:
0.000264
Gnomad AMR exome
AF:
0.000711
Gnomad ASJ exome
AF:
0.0293
Gnomad EAS exome
AF:
0.0000629
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00101
Gnomad OTH exome
AF:
0.00270
GnomAD4 exome
AF:
0.00112
AC:
1613
AN:
1434246
Hom.:
10
Cov.:
32
AF XY:
0.00120
AC XY:
852
AN XY:
712524
show subpopulations
African (AFR)
AF:
0.000210
AC:
7
AN:
33276
American (AMR)
AF:
0.000735
AC:
31
AN:
42202
Ashkenazi Jewish (ASJ)
AF:
0.0278
AC:
713
AN:
25674
East Asian (EAS)
AF:
0.000102
AC:
4
AN:
39088
South Asian (SAS)
AF:
0.00161
AC:
135
AN:
83724
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40432
Middle Eastern (MID)
AF:
0.00327
AC:
16
AN:
4898
European-Non Finnish (NFE)
AF:
0.000504
AC:
557
AN:
1105400
Other (OTH)
AF:
0.00252
AC:
150
AN:
59552
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
101
201
302
402
503
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00128
AC:
195
AN:
152254
Hom.:
4
Cov.:
33
AF XY:
0.00114
AC XY:
85
AN XY:
74432
show subpopulations
African (AFR)
AF:
0.000241
AC:
10
AN:
41552
American (AMR)
AF:
0.00118
AC:
18
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.0282
AC:
98
AN:
3470
East Asian (EAS)
AF:
0.000194
AC:
1
AN:
5164
South Asian (SAS)
AF:
0.00104
AC:
5
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.000882
AC:
60
AN:
67992
Other (OTH)
AF:
0.00142
AC:
3
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
10
20
31
41
51
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00287
Hom.:
1
Bravo
AF:
0.00130
TwinsUK
AF:
0.00108
AC:
4
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000835
AC:
7
ExAC
AF:
0.00133
AC:
158
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Glutamate formiminotransferase deficiency Benign:1
Jan 07, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Jun 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

FTCD: BP4, BS2 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.072
BayesDel_addAF
Benign
-0.54
T
BayesDel_noAF
Benign
-0.59
CADD
Benign
2.5
DANN
Benign
0.81
DEOGEN2
Benign
0.049
T;.;T
Eigen
Benign
-1.8
Eigen_PC
Benign
-1.7
FATHMM_MKL
Benign
0.062
N
LIST_S2
Benign
0.23
.;T;T
M_CAP
Benign
0.010
T
MetaRNN
Benign
0.0058
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-0.21
N;N;N
PhyloP100
-1.5
PrimateAI
Benign
0.32
T
PROVEAN
Benign
-0.090
N;N;N
REVEL
Benign
0.015
Sift
Benign
0.41
T;T;T
Sift4G
Benign
0.59
T;T;T
Polyphen
0.0040
B;B;B
Vest4
0.095
MVP
0.12
MPC
0.064
ClinPred
0.00049
T
GERP RS
-1.6
PromoterAI
0.016
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.019
gMVP
0.055
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61735839; hg19: chr21-47558456; COSMIC: COSV52429060; COSMIC: COSV52429060; API